Literature DB >> 74313

[Combined doxorubicin and bleomycin treatment of metastasising thyroid carcinoma: results in 21 patients (author's transl)].

G Benker, K Hackenberg, H G Hoff, S Seeber, J Ebke, R Windeck, D Reinwein.   

Abstract

The effectiveness of combined cytostatic treatment with doxorubicin and bleomycin was analysed in 21 patients with metastasising thyroid carcinoma which had progressed despite both surgical and radiotherapy. Tumour histology (anaplastic carcinoma in 50%), age and general condition of all patients pointed to a poor prognosis. Significant success (full or partial remission) occurred in eight patients. It is possible that these results can be improved if chemotherapy is started earlier and other cytostatic drugs are used in case of failure of treatment.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 74313     DOI: 10.1055/s-0028-1105595

Source DB:  PubMed          Journal:  Dtsch Med Wochenschr        ISSN: 0012-0472            Impact factor:   0.628


  3 in total

1.  Combined chemotherapy with bleomycin, adriamycin, and platinum in advanced thyroid cancer.

Authors:  P De Besi; B Busnardo; S Toso; M E Girelli; D Nacamulli; N Simioni; D Casara; P Zorat; M V Fiorentino
Journal:  J Endocrinol Invest       Date:  1991-06       Impact factor: 4.256

2.  Chemotherapy of thyroid carcinoma.

Authors:  S Ahuja; H Ernst
Journal:  J Endocrinol Invest       Date:  1987-06       Impact factor: 4.256

3.  Cisplatin based chemotherapy in patients with advanced differentiated thyroid carcinoma refractory to I131 treatment.

Authors:  Osama Hussein; Drumea Karen; Jamal Zidan
Journal:  Indian J Med Paediatr Oncol       Date:  2013-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.